A reassessment of vascular endothelial growth factor in central nervous system pathology

Journal of Neurosurgery

Volumn 103, Issue 5, 2005, Pages 853-868

  Merrill, Marsha J ^a,b   Oldfield, Edward H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood brain barrier; Brain edema; Brain injury; Brain tumor; Vascular endothelial growth factor; Vascular permeability factor

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; NITRIC OXIDE; RECOMBINANT VASCULOTROPIN; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VIRUS VECTOR;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ASTROCYTE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN INJURY; BRAIN TUMOR; CARCINOGENESIS; CELL INTERACTION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIUM CELL; GENE AMPLIFICATION; GENE REARRANGEMENT; GLIOBLASTOMA; GLIOMA; HEMANGIOBLASTOMA; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MOLECULAR MECHANICS; NERVE CELL; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPINE INJURY; STROKE; TUMOR GROWTH; UPREGULATION; VASODILATATION;

ANIMALS; BRAIN DISEASES; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 32044468535     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2005.103.5.0853     Document Type: Review

References (191)

1. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JP, Rosenblum ML: Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 88:513-520, 1998
2. Akiyama C, Yuguchi T, Nishio M, Fujinaka T, Taniguchi M, Nakajima Y, et al: Src family kinase inhibitor PP1 improves motor function by reducing edema after spinal cord contusion in rats. Acta Neurochir Suppl 86:421-423, 2003
3. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Papadakis N, Varakis I: Microvessel density in brain tumors. Anticancer Res 17:4747-4753, 1997
4. Bacic M, Edwards NA, Merrill MJ: Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 12:11-15, 1995
5. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343, 1996
6. Bartholdi D, Rubin BP, Schwab ME: VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J Neurosci 9:2549-2560, 1997
7. Bates DO, Harper SJ: Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39:225-237, 2003
8. Bellomo M, Adamo EB, Deodato B, Catania MA, Mannucci C, Marini H, et al: Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. Pharmacol Res 48:309-317, 2003
9. Benton RL, Whittemore SR: VEGF165 therapy exacerbates secondary damage following spinal cord injury. Neurochem Res 28:1693-1703, 2003
10. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, et al: Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153-159, 1993
11. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220, 1992
12. Bjerkvig R, Lund-Johansen M, Edvardsen K: Tumor cell invasion and angiogenesis in the central nervous system. Curr Opin Oncol 9:223-229, 1997
13. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, et al: The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4:133-146, 2003
14. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521-532, 1992
15. Brown LF, Detmar M, Claffey K, Nagy JA, Feng D, Dvorak AM,et al: Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 79:233-269, 1997
16. Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock JB, Oldfield EH: Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J Neurosurg 67:880-884, 1987
17. Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1988
18. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A: Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159:993-1008, 2001
19. Carmeliet P: Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 4:710-720, 2003
20. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395, 2000
21. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Keickens L, Gertsenstein M, et al: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439, 1996
22. 188. Nat Med 5:495-502, 1999
23. Carmeliet P, Storkebaum E: Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin Cell Dev Biol 13:39-53, 2002
24. Chaudhry IH, O'Donovan DG, Brenchley PEC, Reid H, Roberts ISD: Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 39:409-415, 2001
25. Cheng SY, Huang HJ, Nagane M, Ji XD, Wang D, Shih CCY, et al: Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 93:8502-8507, 1996
26. 189. Proc Natl Acad Sci USA 94:12081-12087, 1997
27. Chodobski A, Chung I, Kozniewska E, Ivanenko T, Chang W, Harrington JF, et al: Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury. Neuroscience 122:853-867, 2003
28. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, et al: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535-1545, 1990
29. Criscuolo GR, Lelkes PI, Rotrosen D, Oldfield EH: Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity. J Neurosurg 71:884-891, 1989
30. Croll SD, Wiegand SJ: Vascular growth factors in cerebral ischemia. Mol Neurobiol 23:121-135, 2001
31. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L: VEGF-receptor signal transduction. Trends Biochem Sci 28:488-494, 2003
32. Damert A, Ikeda E, Risau W: Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J 327:419-423, 1997
33. Danton GH, Dietrich WD: Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62:127-136, 2003
34. Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK: Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permability factor, and host microenvironment. Am J Pathol 149:59-71, 1996
35. Detmar M, Brown LF, Schön MP, Elicker BM, Velasco P, Richard L, et al: Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111:1-6, 1998
36. Dibbens JA, Miller DL, Damert A, Risau W, Vadas MA, Goodall GJ: Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell 10:907-919, 1999
37. Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW: Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol 27:163-173, 1998
38. Dor Y, Djonov V, Keshet E: Making vascular networks in the adult: branching morphogenesis without a roadmap. Trends Cell Biol 13:131-136, 2003
39. Dvorak HF, Detmar M, Claffey KP, Nagy JA, Van de Water L, Senger DR: Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 107:233-235, 1995
40. Facchiano F, Fernandez E, Mancarella S, Maira G, Miscusi M, D'Arcangelo D, et al: Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J Neurosurg 97:161-168, 2002
41. Feldman AL, Libutti SK: Progress in antiangiogenic gene therapy of cancer. Cancer 89:1181-1194, 2000
42. Ferrara N: Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280:C1358-C1366, 2001
43. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442, 1996
44. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 9:669-676, 2003
45. Finkenzeller G, Technau A, Marmé D: Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun 208:432-439, 1995
46. Fischer S, Renz D, Schaper W, Karliczek GF: In vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor. Eur J Pharmacol 411:231-243, 2001
47. Fisher MJ, Adamson PC: Anti-angiogenic agents for the treatment of brain tumors. Neuroimaging Clin N Am 12:477-499, 2002
48. Forstreuter F, Lucius R, Mentlein R: Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132:93-98, 2002
49. Fukumura D, Xu L, Chen Y, Gohongi T, Seed B, Jain RK: Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61:6020-6024, 2001
50. Gerber HP, Dixit V, Ferrara N: Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273:13313-13316, 1998
51. Goldbrunner RH, Bendszus M, Sasaki M, Kraemer T, Plate KH, Roosen K, et al: Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging. Neurosurgery 47:921-930, 2000
52. Gollmer JC, Ladoux A, Gioanni J, Paquis P, Dubreuil A, Chatel M, et al: Expression of vascular endothelial growth factor-b in human astrocytoma. Neuro-Oncol 2:80-86, 2000
53. Gossmann A, Helbich TH, Kuriyama N, Ostrowitzki S, Roberts TPL, Shames DM, et al: Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging 15:233-240, 2002
54. Haddad SF, Moore SA, Schelper RL, Goeken JA: Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. J Neuropathol Exp Neurol 51:488-492, 1992
55. Harrigan MR, Ennis SR, Masada T, Keep RF: Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery 50:589-598, 2002
56. Harris OA, Chang SD, Harris BT, Adler JR: Acquired cerebral arteriovenous malformation induced by an anaplastic astrocytoma: an interesting case. Neurol Res 22:473-477, 2000
57. Hashimoto T, Emala CW, Joshi S, Mesa-Tejada R, Quick CM, Feng L, et al: Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47:910-919, 2000
58. Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL: Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 89:111-113, 2001
59. Hatva E, Jääskeläinen J, Hirvonen H, Alitalo K, Haltia M: Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. J Neuropathol Exp Neurol 55:1124-1133, 1996
60. Hatva E, Kaipainen A, Mentula P, Jääskeläinen J, Paetau A, Haltia M, et al: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146:368-378, 1995
61. Hayashi T, Abe K, Itoyama Y: Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 18:887-895, 1998
62. Hayashi T, Abe K, Suzuki H, Itoyama Y: Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke 28:2039-2044, 1997
63. Hayashi T, Noshita N, Sugawara T, Chan PH: Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J Cereb Blood Flow Metab 23:166-180, 2003
64. Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, et al: Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest 98:1400-1408, 1996
65. Herold-Mende C, Steiner HH, Andl T, Riede D, Buttler A, Reisser C, et al: Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab Invest 79:1573-1582, 1999
66. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998, 1999
67. Holash J, Wiegand SJ, Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356-5362, 1999
68. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814, 1991
69. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037, 1992
70. Ikeda E, Achen MG, Breier G, Risau W: Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270:19761-19766, 1995
71. 164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198:483-489, 2003
72. Issa R, Krupinski J, Bujny T, Kumar S, Kaluza J, Kumar P: Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest 79:417-425, 1999
73. Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48:2641-2658, 1988
74. Jin KL, Mao XO, Greenberg DA: Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 97:10242-10247, 2000
75. Johansson M, Brännström T, Bergenheim AT, Henriksson R: Spatial expression of VEGF-A in human glioma. J Neurooncol 59:1-6, 2002
76. Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, et al: Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 160:501-509, 2002
77. Kalaria RN, Cohen DL, Premkumar DR, Nag S, LaManna JC, Lust WD: Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 62:101-105, 1998
78. Kaya M, Chang L, Truong A, Brightman M: Effects of urokinase and vascular endothelial growth factor (VEGF) on brain vessels. Soc Neurosci Abstr 22:53, 1996
79. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-1312, 1989
80. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66:865-874, 1987
81. Kelly PJ, Suddith RL, Hutchison HT, Werrbach K, Haber B: Endothelial growth factor present in tissue culture of CNS tumors. J Neurosurg 44:342-346, 1976
82. Kendall RL, Wang G, Thomas KA: Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226:324-328, 1996
83. Kiliç T, Pamir MN, Küllü S, Eren F, Ozek MM, Black PM: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1192, 2000
84. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY: Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells. J Biol Chem 276:7614-7620, 2001
85. Kirk SL, Karlik SJ: VEGF and vascular changes in chronic neuroinflammation. J Autoimmun 21:353-363, 2003
86. Kirsch M, Schackert G, Black PM: Anti-angiogenic treatment strategies for malignant brain tumors. J Neurooncol 50:149-163, 2000
87. Koike Y, Uzuki M, Kokubun S, Sawai T: Angiogenesis and inflammatory cell infiltration in lumbar disc herniation. Spine 28:1928-1933, 2003
88. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T: Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 50:117-126, 2002
89. Korkolopoulou P, Patsouris E, Konstantinidou AE, Pavlopoulos PM, Kavantzas N, Boviatsis E, et al: Hypoxia-inducible factor 1α/vascular endothelial growth factor axis in 46 astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol 30:267-278, 2004
90. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M: VEGF and flt. Expression time kinetics in rat brain infarct. Stroke 27:1865-1873, 1996
91. Krum JM, Khaibullina A: Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Exp Neurol 181:241-257, 2003
92. Krum JM, Mani N, Rosenstein JM: Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110:589-604, 2002
93. Krum JM, Rosenstein JM: VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp Neurol 154:57-65, 1998
94. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, Stavrou D, et al: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 61:6624-6628, 2001
95. 165 induces progression of melanoma brain metastases without induction of sprouting angiogenesis. Cancer Res 62:341-345, 2002
96. Leenders WPJ, Küsters B, de Waal RMW: Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis. Endothelium 9:83-87, 2002
97. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A: Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 57:874-882, 1998
98. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362-372, 1996
99. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989
100. Liu Y, Cox SR, Morita T, Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 77:638-643, 1995
101. Machein MR, Kullmer J, Fiebich BL, Plate KH, Warnke PC: Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery 44:732-741, 1999
102. Machein MR, Kullmer J, Rönicke V, Machein U, Krieg M, Damert A, et al: Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol 25:104-112, 1999
103. Machein MR, Plate KH: VEGF in brain tumors. J Neurooncol 50:109-120, 2000
104. Maher ER, Kaelin WG Jr: von Hippel-Lindau disease. Medicine (Baltimore) 76:381-391, 1997
105. Marti HJH, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, et al: Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156:965-976, 2000
106. Martínez-Estrada OM, Rodríguez-Millán E, González-de Vicente E, Reina M, Vilaró S, Fabre M: Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18:2538-2544, 2003
107. Masood K, Besnard F, Su Y, Brenner M: Analysis of a segment of the human glial fibrillary acidic protein gene that directs astrocyte-specific transcription. J Neurochem 61:160-166, 1993
108. Mattei MG, Borg JP, Rosnet O, Marmé D, Birnbaum D: Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics 32:168-169, 1996
109. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88:9026-9030, 1991
110. Mentlein R, Held-Feindt J: Angiogenesis factors in gliomas: a new key to tumour therapy? Naturwissenschaften 90:385-394, 2003
111. Monacci WT, Merrill MJ, Oldfield EH: Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264:C995-C1002, 1993
112. Nag S: The blood-brain barrier and cerebral angiogenesis: lessons from the cold-injury model. Trends Mol Med 8:38-44, 2002
113. Nag S, Takahashi JL, Kilty DW: Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J Neuropathol Exp Neurol 56:912-921, 1997
114. Nagashima G, Suzuki R, Asai JI, Fujimoto T: Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases. Clin Neurol Neurosurg 104:125-131, 2002
115. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M: Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341:309-315, 1998
116. Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA: Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 220:112-121, 2001
117. Nordal RA, Nagy A, Pintilie M, Wong CS: Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Clin Cancer Res 10:3342-3353, 2004
118. Pagès G, Pouysségur J: Transcriptional regulation of the Vascular Endothelial Growth Factor gene - a concert of activating factors. Cardiovasc Res 65:564-573, 2005
119. Papavassiliou E, Gogate N, Proescholdt M, Heiss JD, Walbridge S, Edwards NA, et al: Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J Neurosci Res 49:451-460, 1997
120. Papetti M, Herman IM: Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 282:C947-C970, 2002
121. Paul R, Zhang ZG, Eliceiri BP, Jiang Q, Boccia AD, Zhang RL, et al: Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 7:222-227, 2001
122. Pedersen EB, McNulty JA, Castro AJ, Fox LM, Zimmer J, Finsen B: Enriched immune-environment of blood-brain barrier deficient areas of normal adult rats. J Neuroimmunol 76:117-131, 1997
123. Pekala P, Marlow M, Heuvelman D, Connolly D: Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-α, but not by insulin. J Biol Chem 265:18051-18054, 1990
124. Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906, 1991
125. Pietsch T, Valter MM, Wolf HK, von Deimling A, Huang HJ, Cavenee WK, et al: Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93:109-117, 1997
126. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822-5827, 1993
127. Plate KH, Breier G, Weich HA, Mennel HD, Risau W: Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520-529, 1994
128. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848, 1992
129. Proescholdt MA, Heiss JD, Walbridge S, Mühlhauser J, Capogrossi MC, Oldfield EH, et al: Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol 58:613-627, 1999
130. Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ: Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol 61:914-925, 2002
131. Ribatti D, Vacca A, Dammacco F: New non-angiogenesis dependent pathways for tumour growth. Eur J Cancer 39:1835-1841, 2003
132. Robinson CJ, Stringer SE: The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114:853-865, 2001
133. Rosenstein JM, Krum JM: New roles for VEGF in nervous tissue - beyond blood vessels. Exp Neurol 187:246-253, 2004
134. Rosenstein JM, Mani N, Silverman WF, Krum JM: Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 95:7086-7091, 1998
135. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38:915-925, 1996
136. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, et al: Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2:306-314, 2000
137. Ruhrberg C: Growing and shaping the vascular tree: multiple roles for VEGF. Bioessays 25:1052-1060, 2003
138. Salhia B, Angelov L, Roncari L, Wu X, Shannon P, Guha A: Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res 883:87-97, 2000
139. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, et al: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189-1193, 1995
140. Sarid J: Identification of a cis-acting positive regulatory element of the glial fibrillary acidic protein gene. J Neurosci Res 28:217-228, 1991
141. Sato Y: Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy. Int J Clin Oncol 8:200-206, 2003
142. Scherer HJ: The forms of growth in gliomas and their practical significance. Brain 63:1-35, 1940
143. Schiffer D, Chiò A, Giordana MT, Mauro A, Migheli A, Vigliani MC: The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study. Acta Neuropathol 77:369-378, 1989
144. Schmid-Elsaesser R: General considerations and review of the literature, in Steiger HJ, Schmid-Elsaesser R, Muacevic A, Brückmann H, Wowra B (eds): Neurosurgery of Arteriovenous Malformations and Fistulas: a Multimodal Approach. New York: Springer-Verlag/Wien, 2002, pp 1-56
145. Semenza GL: HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474-1480, 2000
146. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983
147. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66, 1995
148. Shibuya M: Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 33:409-420, 2001
149. Shibuya M: Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E. Cancer Sci 94:751-756, 2003
150. Shore PM, Jackson EK, Wisniewski SR, Clark RSB, Adelson PD, Kochanek PM: Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children. Neurosurgery 54:605-612, 2004
151. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
152. Shweiki D, Neeman M, Itin A, Keshet E: Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 92:768-772, 1995
153. Skirgaudas M, Awad IA, Kim J, Rothbart D, Criscuolo G: Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery 39:537-547, 1996
154. Sköld M, Cullheim S, Hammarberg H, Piehl F, Suneson A, Lake S, et al: Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur J Neurosci 12:3675-3686, 2000
155. Sonstein WJ, Kader A, Michelsen WJ, Llena JF, Hirano A, Casper D: Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study. J Neurosurg 85:838-845, 1996
156. Stiver SI, Tan X, Brown LF, Hedley-Whyte ET, Dvorak HF: VEGF-A angiogenesis induces a stable neovasculature in adult murine brain. J Neuropathol Exp Neurol 63:841-855, 2004
157. Storkebaum E, Carmeliet P: VEGF: a critical player in neurodegeneration. J Clin Invest 113:14-18, 2004
158. Sundberg C, Nagy JA, Brown LF, Feng D, Eckelhoefer IA, Manseau EJ, et al: Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 158:1145-1160, 2001
159. Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, et al: Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 94:972-977, 2001
160. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H: Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg 103:29-32, 2001
161. Suzuki R, Fukai N, Nagashijma G, Asai JI, Itokawa H, Nagai M, et al: Very early expression of vascular endothelial growth factor in brain oedema tissue associated with brain contusion. Acta Neurochir Suppl 86:277-279, 2003
162. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, et al: Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56:2185-2190, 1996
163. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, et al: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586, 1992
164. Thompson WD, Shiach KJ, Fraser RA, McIntosh LC, Simpson JG: Tumours acquire their vasculature by vessel incorporation, not vessel ingrowth. J Pathol 151:323-332, 1987
165. Tischer E, Gospodarowicz D, Mitchell R, Silva M, Schilling J, Lau K, et al: Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 165:1198-1206, 1989
166. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA: Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 48:359-368, 2001
167. van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, et al: VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104:1613-1620, 1999
168. Vaquero J, Zurita M: Tissue expression of 165-aa vascular permeability factor after spinal cord injury is not influenced by dexamethasone administration in rats. Neurosci Lett 365:214-217, 2004
169. Vaquero J, Zurita M, Cincu R: Vascular endothelial growth-permeability factor in granulation tissue of chronic subdural haematomas. Acta Neurochir (Wein) 144:343-347, 2002
170. Vaquero J, Zurita M, de Oya S, Coca S: Vascular endothelial growth/permeability factor in spinal cord injury. J Neurosurg (Spine 2) 90:220-223, 1999
171. Vaupel P, Kallinowski F, Okunieff P: Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49:6449-6465, 1989
172. Veikkola T, Alitalo K: VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211-220, 1999
173. Vincenti V, Cassano C, Rocchi M, Persico MG: Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493-1495, 1996
174. Vogel J, Hörner C, Haller C, Kuschinsky W: Heterologous expression of human VEGF165 in rat brain: dose-dependent, heterogeneous effects on CBF in relation to vascular density and cross-sectional area. J Cereb Blood Flow Metab 23:423-431, 2003
175. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfield EH, et al: von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28:540-543, 1997
176. Wei MH, Popescu NC, Lerman MI, Merrill MJ, Zimonjic DB: Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12. Hum Genet 97:794-797, 1996
177. Weigel R, Schilling L, Schmiedek P: Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir (Wein) 143:811-819, 2001
178. Wesseling P, Ruiter DJ, Burger PC: Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 32:253-265, 1997
179. Wesseling P, Vandersteenhoven JJ, Downey BT, Ruiter DJ, Burger PC: Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed routinely processed material. Acta Neuropathol 85:508-514, 1993
180. Widenfalk J, Lipson A, Jubran M, Hofstetter C, Ebendal T, Cao Y, et al: Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 120:951-960, 2003
181. Xu L, Fukumura D, Jain RK: Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem 277:11368-11374, 2002
182. Yang GY, Xu B, Hashimoto T, Huey M, Chaley T Jr, Wen R, et al: Induction of focal angiogenesis through adenoviral vector mediated vascular endothelial cell growth factor gene transfer in the mature mouse brain. Angiogenesis 6:151-158, 2003
183. Yang ZJ, Bao WL, Qiu MH, Zhang LM, Lu SD, Huang YL, et al: Role of vascular endothelial growth factor in neuronal DNA damage and repair in rat brain following a transient cerebral ischemia. J Neurosci Res 70:140-149, 2002
184. Zachary I: Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol 280:C1375-C1386, 2001
185. Zadeh G, Guha A: Angiogenesis in nervous system disorders. Neurosurgery 53:1362-1376, 2003
186. Zagzag D, Friedlander DR, Margolis B, Grumet M, Semenza GL, Zhong H, et al: Molecular events implicated in brain tumor angiogenesis and invasion. Pediatr Neurosurg 33:49-55, 2000
187. Zeng H, Dvorak HF, Mukhopadhyay D: Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 276:26969-26979, 2001
188. Zhang HT, Scott PAE, Morbidelli L, Peak S, Moore J, Turley H, et al: The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83:63-68, 2000
189. Zhang Z, Chopp M: Vacular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med 12:62-66, 2002
190. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, et al: VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106:829-838, 2000
191. Ziemer LS, Koch CJ, Maity A, Magarelli DP, Horan AM, Evans SM: Hypoxia and VEGF mRNA expression in human tumors. Neoplasia 3:500-508, 2001